Cost-Effectiveness Modelling of a 3-Month Tight Control Patient Management of Rheumatoid Arthritis with Certolizumab Pegol in France
Abstract
Authors
F. Fagnani T. Pham P. Claudepierre F. Berenbaum T. De Chalus C. Saadoun J.M. Joubert B. Fautrel